Concepedia

Pharmacokinetics of CTLA4Ig fusion protein in healthy volunteers and patients with rheumatoid arthritis

Ying Ma, Birong Lin, Bei Lin, Sheng Hou, Weizhu Qian, Jing Li, Min Tan, Jian Ma, Bohua Li, Hao Wang,

Acta Pharmacologica Sinica · 2009 · 33 citations · 8 references

DOIFull text

Open access

Concepts

References

8

Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition

Mark C. Genovese, Jean‐Claude Becker, Michael Schiff et al. · New England Journal of Medicine · 2005 · 1.2K citations · Full text

, , +16

Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig

Joel M. Kremer, René Westhovens, Marc Léon et al. · New England Journal of Medicine · 2003 · 1.1K citations · Full text

, , +17

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

Judith R. Abrams, Mark Lebwohl, Cynthia Guzzo et al. · Journal of Clinical Investigation · 1999 · 598 citations · Full text

, , +17

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve‐month results of a phase iib, double‐blind, randomized, placebo‐controlled trial

Joel M. Kremer, Maxime Dougados, Paul Emery et al. · Arthritis & Rheumatism · 2005 · 446 citations · Full text

, , +16

Costimulatory blockade in patients with rheumatoid arthritis: A pilot, dose‐finding, double‐blind, placebo‐controlled clinical trial evaluating CTLA‐4Ig and LEA29Y eighty‐five days after the first infusion

Larry W. Moreland, Rieke Alten, Filip Van den Bosch et al. · Arthritis & Rheumatism · 2002 · 384 citations

, , +17